May 7 (Reuters) - Vanda Pharmaceuticals Inc ( VNDA ):

* FUTURE PAK INCREASES BID FOR VANDA PHARMACEUTICALS TO

INCLUDE

CVRS IN ADDITION TO $7.25 TO $7.75 PER SHARE IN CASH

* FUTURE PAK LLC - REMAINS COMMITTED TO A TRANSACTION

DESPITE

ACTIONS BY VANDA TO LIMIT STOCKHOLDER INFLUENCE AND ITS REFUSAL

TO ENGAGE CONSTRUCTIVELY

* FUTURE PAK - INCREASED OFFER INCLUDES UP TO $260 MILLION

OF

POTENTIAL CVR PAYMENTS

* FUTURE PAK LLC - REITERATES IT WOULD NOT REQUIRE A

FINANCING

CONTINGENCY IN CONNECTION WITH A TRANSACTION

* FUTURE PAK LLC- FUTURE PAK REITERATES IT HAS FULL SUPPORT

OF ITS

STRATEGIC FINANCIAL PARTNER, COLBECK CAPITAL MANAGEMENT

Source text for Eikon:

Further company coverage: